How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

SIMPLE SUMMARY: Despite improvements in the early identification and successful control of primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal improvements in survival. This review focuses on the tumor microenvironment and the cross-talk between tumor and immun...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Marseglia, Mariarosaria, Amaro, Adriana, Solari, Nicola, Gangemi, Rosaria, Croce, Elena, Tanda, Enrica Teresa, Spagnolo, Francesco, Filaci, Gilberto, Pfeffer, Ulrich, Croce, Michela
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8122936/
https://ncbi.nlm.nih.gov/pubmed/33922591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados